Methylphenidate Extended-Release Dose Equivalent
For a patient taking methylphenidate 10 mg in the morning and 10 mg at lunch (total 20 mg daily), the equivalent once-daily extended-release dose is 20 mg of Ritalin LA or Metadate CD, or 18 mg of Concerta (OROS-methylphenidate). 1, 2
Conversion Guidelines
The American Academy of Child and Adolescent Psychiatry provides clear conversion instructions: add the morning and noon immediate-release doses together to determine the required extended-release dose. 1 For example, a patient on 10 mg in the morning and 10 mg at noon would take 20 mg of sustained-release methylphenidate in the morning. 1
Specific Formulation Equivalents
For OROS-methylphenidate (Concerta):
- 18 mg Concerta once daily ≈ 5 mg immediate-release three times daily (total 15 mg) 2
- 36 mg Concerta once daily ≈ 10 mg immediate-release three times daily (total 30 mg) 2
Since your patient takes 20 mg total daily, 18 mg Concerta is the closest FDA-approved dose and provides approximately 12 hours of coverage. 1, 2
For bimodal extended-release formulations (Ritalin LA, Metadate CD):
- 20 mg once daily is the direct equivalent to 10 mg + 10 mg immediate-release 2
- These formulations provide approximately 8 hours of clinical action 1, 2
Critical Pharmacokinetic Differences
Concerta (OROS-methylphenidate) provides 10-12 hours of symptom control with an osmotic pump delivery system, making it superior for full-day coverage. 1, 2 However, it has a delayed onset of 1-2 hours compared to immediate-release formulations. 2
Ritalin LA and Metadate CD provide approximately 8 hours of action with an early peak followed by sustained release. 1, 2 These bimodal formulations release roughly 50% of the dose immediately and 50% after a delay, creating two distinct plasma peaks. 2
Older sustained-release formulations (MPH-SR20) are inferior because they provide only 4-6 hours of clinical action with delayed onset and lower peak concentrations, making them less effective than immediate-release formulations. 1, 2
Practical Implementation
Start with 18 mg Concerta once daily in the morning if 12-hour coverage is needed for school, homework, and evening activities. 1, 2 Alternatively, use 20 mg Ritalin LA or Metadate CD if 8-hour coverage is sufficient and earlier onset is preferred. 2
Administer the dose in the morning (preferably before mid-morning) to minimize insomnia risk. 2, 3 The medication may be taken with or without food, though taking it with meals can reduce gastrointestinal discomfort. 2
Monitoring Requirements
During the first week after switching, monitor for:
- ADHD symptom control using standardized rating scales 1, 4
- Common adverse effects including agitation, insomnia, decreased appetite, headache, tachycardia, and palpitations 2, 3
- Blood pressure and pulse 1, 4
If symptom control is inadequate after one week:
- For Concerta: increase to 36 mg once daily 2
- For Ritalin LA/Metadate CD: increase to 30 mg once daily 2
Common Pitfalls to Avoid
Do not assume all extended-release formulations are equivalent. Concerta provides 12 hours of coverage while Ritalin LA/Metadate CD provide only 8 hours, which may leave patients unmedicated during critical evening periods. 1, 2
Do not use older sustained-release formulations (MPH-SR20) expecting full-day coverage, as they only provide 4-6 hours of action with delayed onset and lower efficacy. 1, 2
Do not schedule doses after 2:00 PM if insomnia is a concern, as methylphenidate's short 2-3 hour elimination half-life means late dosing can interfere with sleep onset. 2
If breakthrough symptoms occur in late afternoon/evening with 8-hour formulations, consider either switching to Concerta for 12-hour coverage or adding a small immediate-release dose (5 mg) in the afternoon rather than increasing the morning extended-release dose. 1, 2